Clinical Trials Logo

Clinical Trial Summary

This study investigates stimulation of the posterior pituitary gland by oral Macimorelin (a ghrelin receptor Agonist) to be a novel diagnostic test in the polyuria-polydipsia syndrome.


Clinical Trial Description

Copeptin measurements upon intravenous arginine stimulation discriminate patients with diabetes insipidus versus patients with primary polydipsia with a high diagnostic accuracy. An oral test would be easier to perform, causes less risks and discomfort for the patients and would require less resources in clinical practice. This study investigates stimulation of the posterior pituitary gland by oral Macimorelin (a ghrelin receptor Agonist) to be a novel diagnostic test in the polyuria-polydipsia syndrome. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03844217
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Completed
Phase N/A
Start date March 7, 2019
Completion date July 16, 2019

See also
  Status Clinical Trial Phase
Completed NCT01879137 - Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome N/A